Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
09/2005
09/07/2005CN1217652C Cosmetic method of treating skin
09/07/2005CN1217651C Skin care compositions containing cis-9, trans-11 linoleic acid
09/06/2005US6939539 present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons
09/06/2005CA2067690C Amino acid derivatives
09/02/2005WO2004073646A2 Treatment of pain through expression of opioid receptors
09/02/2005CA2555996A1 Treatment of pain through expression of opioid receptors
09/01/2005WO2005080488A1 Use of a plastic composition and a product obtained thereby
09/01/2005WO2005079155A2 Photoreactive compound specifically binding to calcium binding proteins
09/01/2005WO2005055949A3 Sustained release preparations composed of biocompatible complex microparticles
09/01/2005WO2005053615A9 Novel differential imaging method
09/01/2005WO2005053609A3 Methods of nad+-dependent deacetylase inhibitors
09/01/2005WO2005048934A3 Mangosteen protein supplement
09/01/2005WO2005046586A8 M3 muscarinic acetylcholine receptor antagonists
09/01/2005WO2005044193A3 Product and process for increasing compactibility of carbohydrates
09/01/2005WO2005044177A3 Method for producing abrasive non-woven cloth
09/01/2005WO2005041898A3 Blood substitutes
09/01/2005WO2005041878A3 Compositions and methods for increasing hdl and hdl-2b levels
09/01/2005WO2005041853B1 Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines.
09/01/2005WO2005039482A3 Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof
09/01/2005WO2005037200A8 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
09/01/2005WO2005034880A3 Thiophene and benzothiophene hydroxamic acid derivatives
09/01/2005WO2005030137A3 Improving biomechanical performance of irradiated biological material
09/01/2005WO2005011593A3 Improved binding of pantoprazole to the acid pump
09/01/2005WO2005004792A3 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment
09/01/2005WO2005002519A3 Amphiphilic pyridinium compounds, method of making and use thereof
09/01/2005WO2005002508B1 Macromolecular platinum chelates
09/01/2005WO2005002506A3 Method for treating diseases using hsp90-inhibiting agents in combination with antimetabolites
09/01/2005WO2005002504A3 Protection against vertical transmission of pathogenic infections
09/01/2005WO2005000219A3 Composition for blocking hiv binding to dendritic cells and methods of use thereof
09/01/2005WO2005000197A3 Selective serine/threonine kinase inhibitors
09/01/2005WO2004110343A3 2-amino-9-(2-substituted ethyl)purines and preparing methods for 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]- 2- aminopurine using the same
09/01/2005WO2004096159A3 Saposin c-dops: a novel anti-tumor agent
09/01/2005WO2004082600A3 Method and system for administering a drug
09/01/2005WO2004073656A9 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
09/01/2005WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases
09/01/2005US20050192353 Treating or preventing restless legs syndrome using prodrugs of GABA analogs
09/01/2005US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs)
09/01/2005US20050192281 Nitrone compounds, prodrugs and pharmaceuticals compositons of the same to treat human disorders
09/01/2005US20050192270 Using synergistic mixture of serotonin receptor antagonist and noradrenaline reuptake inhiitor; diarrhea, consti[ation, gastrointestinal disorders
09/01/2005US20050192239 Methods for identifying risk of breast cancer and treatments thereof
09/01/2005US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation
09/01/2005US20050191654 Compositions and methods for diagnosing and treating chronic lymphocytic leukemia
09/01/2005US20050191343 Micellar systems useful for delivery of lipophilic or hydrophobic compounds
09/01/2005US20050191336 Dissolving thin film xanthone supplement
09/01/2005US20050191276 Treatment of inflammatory bowel disease through induction of indoleamine 2.3-dioxygenase
09/01/2005CA2556054A1 Photoreactive compound specifically binding to calcium binding proteins
08/2005
08/31/2005EP1567491A2 Compounds for inhibition of hiv infection by blocking hiv entry
08/31/2005EP1567198A2 Materials and methods for treating ocular-related disorders
08/31/2005EP1567188A2 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases
08/31/2005EP1567185A2 Broad spectrum anti-viral therapeutics and prophylaxis
08/31/2005EP1567182A2 Preventing desensitization of receptors
08/31/2005EP1567181A2 Methods for treatment of helicobacter pylori-associated disorders
08/31/2005EP1567171A1 New use of dextran sulfate
08/31/2005EP1567127A2 Method of modifying the release profile of sustained release compositions
08/31/2005EP1567122A2 Functional fragrance precursor
08/31/2005EP1567101A2 Prophylactic treatment methods
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005CN1662498A Novel tetrahydropyridine derivatives as renin inhibitors
08/31/2005CN1662497A Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
08/31/2005CN1662266A Method and device for the delivery of a substance
08/31/2005CN1662258A Compositions comprising dietary fat complexer and methods for their use
08/31/2005CN1662235A Use of MGLUR5 antagonists for the treatment of GERD
08/31/2005CN1660925A Use of a plastic composition and a product obtained thereby
08/31/2005CN1660779A Mono- and disubstituted 3-propyl gamma-aminobutyric acids
08/30/2005US6936285 Use of Ginkgo biloba extracts for preparing a medicine
08/30/2005CA2164060C Lactate dehydrogenase inhibitors in cosmetic compositions
08/30/2005CA2136331C New pharmaceutical uses of krill enzymes
08/25/2005WO2005077391A1 New synbiotic use
08/25/2005WO2005077362A1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
08/25/2005WO2005077319A2 Hair treatment compositions comprising a protein disulfide isomerase
08/25/2005WO2005077189A1 Method of treatment
08/25/2005WO2005055947A3 Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions
08/25/2005WO2005055945A3 Mucoadhesive drug delivery devices and methods of making and using thereof
08/25/2005WO2005053616A3 Antimicrobial composition
08/25/2005WO2005044182A3 Compositions of botanical extracts for cancer therapy
08/25/2005WO2005037194A3 Collagen interactions with prostate cancer cells
08/25/2005WO2005011601A3 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders
08/25/2005WO2005007108A3 Asymmetric disulfides and methods of using same
08/25/2005WO2004098513A3 Nasal administration of the lh-rh analog leuprolide
08/25/2005WO2004093820A3 Methods and compositions for solid tumor treatment
08/25/2005WO2004087069A3 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-PROLIFERATIVE AGENTS
08/25/2005WO2004043372A3 Boron coated straw neutron detector
08/25/2005US20050187409 Inhibitors of RNase P proteins as antibacterial compounds
08/25/2005US20050187276 Compounds, compositions and methods
08/25/2005US20050187230 Compounds and compositions as protein kinase inhibitors
08/25/2005US20050187226 A1 adenosine receptor antagonists
08/25/2005US20050187186 useful for the treatment of cancer and other hyperproliferative disorders; a sphingolipid; lactic acid; and optionally a stabilizing agent; emulsion
08/25/2005US20050187175 Methods and compositions for CPG15-2
08/25/2005US20050187162 Novel peptide with osteogenic activity
08/25/2005US20050187154 bone morphogenetic proteins play an important role in adipocyte differentiation; promote brown adipocyte tissue (BAT) differentiation and inhibits white adipose tissue (WAT) adipogenesis
08/25/2005US20050186591 Method of treating neurodegenerative disease
08/25/2005US20050186220 derived from canine distemper virus; vaccines for inducing immune response
08/25/2005US20050186213 Anti-PECAM therapy for metastasis suppression
08/25/2005US20050186185 Mammalian cell modified with genes encoding plant late embryogenesis protein HVA1, trehalose transport protein, or a trehalose synthesis pathway; freezing and/or drying organs for storage prior to use
08/25/2005US20050186135 therapy for tumors, lesions, cancer by in situ supplying peroxide and hypochlorite; drug delivery
08/25/2005CA2555151A1 New synbiotic use
08/25/2005CA2555149A1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
08/24/2005EP1566179A2 Agent containing fat (oil) which contains onion extract, the production and use thereof
08/24/2005EP1565583A2 Hiv vaccine formulations
08/24/2005EP1565582A2 Methods for identifying risk of breast cancer and treatments thereof
1 ... 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 ... 295